In the present study, we demonstrate for the first time that Ped can exert anti-inflammatory and anti-apoptotic effects to slow down AD pathology through the AMPK/GSK-3β/Nrf2 signaling pathway. This evidence concerns the gene GSK3B and Alzheimer disease.